Treatment of Three Patients with Systemic Mastocytosis with Interferon Alpha-2b

References

• Austen K. F. Systemic mastocytosis. New Eng. J. Med. 1992; 326: 639–340
   PubMed Web of Science ®Google Scholar
• Metcalfe D. D. Classification and diagnosis of mastocytosis, current status. J. Invest. Dermatol. 1991; 96: 2S–4S
   Web of Science ®Google Scholar
• Metcalfe D. D., Costa J. J., Burd P. R. Mast cells and basophils. Inflammation: Basic Principles and Clinical Correlates, J. I. Gallin, I. M. Goldstein, R. Snyderman. Raven Press, Ltd., New York 1992; 709–725
   Google Scholar
• Horny H. P., Ruck M., Wehrmann M., Kaiserling E. Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurence of myeloproliferative disorders. Br. J. Haematol 1990; 76: 186–193
   PubMed Web of Science ®Google Scholar
• Lawrence J. B., Friedman B. S., Travis W. D., Chinchilli V. M., Metcalfe D. D., Gralnick H. R. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am. J. Med. 1991; 91: 612–624
   PubMed Web of Science ®Google Scholar
• Metcalfe D. D. The treatment of mastocytosis: current status. J. Invest. Dermatol. 1991; 96: 55S–59S
   Web of Science ®Google Scholar
• Kluin-Nelemans H. C., Jansen J. H., Bruekelman H., et al. Response to interferon alpha-2b in a patient with systemic mastocytosis. New Engl. J. Med. 1992; 326: 619–623
   PubMed Web of Science ®Google Scholar
• Kirshenbaum A. S., Kessler S. W., Goff J. P., Metcalfe D. D. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J. Immunol. 1991; 146: 1410–1415
   PubMed Web of Science ®Google Scholar
• Einhorn S., Strander H. Interferon treatment of human malignancies-a short review. Med. Oncol. Tumor Pharmacother. 1993; 10: 25–29
   PubMedGoogle Scholar
• Griesshammer M., Hehlmann R., Hochbaus A., et al. Interferon in chronic myeloid leukemia. Ann. Hematol. 1993; 67: 101–106
   PubMed Web of Science ®Google Scholar
• Niederle N., Kloke O., Wnadl U. B., Becher R., Moritz T., Opalka B. Long-term treatment of chronic myelogenous leukemia with different interferons: results from three studies. Leukemia and Lymphoma 1993; 9: 111–119
   PubMed Web of Science ®Google Scholar
• Pardini S., Bosincu L., Bonfigli S., Dore F., Longinotti M. Anaphylactic-like syndrome in systemic mastocytosis treated with alpha-2-interferon. Acta. Haematol. 1991; 85: 220
   PubMed Web of Science ®Google Scholar
• Sewall K. L. Immunotherapy and other novel therapies, including biologic response modifiers, apheresis and dietary modifications. Curr. Opin. Rheumatol. 1993; 5: 293–298
   PubMedGoogle Scholar
• Schwartz L. B., Bradford T. R., Rouse C., et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J. Clin. Immunol. 1994; 14: 190–204
   PubMed Web of Science ®Google Scholar
• Rottem M., Okada T., Goff J. P., Metcalfe D. D. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34/FcϵRI- cell population. Blood 1994; 84: 2489–2496
   PubMed Web of Science ®Google Scholar
• Chen C. C., Andrich M. P., Mican J. M., Metcalfe D. D. A retrospective analysis of bone scan abnormalities in 73 patients with mastocytosis: correlation with disease category and prognosis. J. Nucl. Med. 1994; 35: 1471–1475
   PubMed Web of Science ®Google Scholar
• Griesinger F., Bergmann L., Mitrou P. S., Hoelzer D. Interferons in the treatment of malignant mastocytosis (MM) and CMMol developing in MM. Blut 1987; 55: 309
   Google Scholar
• Czarnetzki B. M., Algermissen B., Jeep S., et al. Interferon treatment of patients with chronic urticaria and mastocytosis. J. Am. Acad. Dermatol. 1994; 3: 500–501
   Google Scholar
• Gutterman J. U. Cytokine therapeutics: lessons from interferon alpha. PNAS 1994; 91: 1198–1205
   PubMed Web of Science ®Google Scholar
• Lee S. B., Esteban M. The inteferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 1994; 199: 491–496
   PubMed Web of Science ®Google Scholar
• Lee T. G., Tomita J., Hovanessian A. G., Katze M. G. Characterization and regulation of the 58,000 dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. J. Biol Chem. 1992; 267: 14238–14243
   PubMed Web of Science ®Google Scholar
• Merimsky O., Chaitnik S. Anticancer Drugs 1992; 19(3)567–570, Neurotoxicity of interferon-alpha
   Web of Science ®Google Scholar
• Aul C., Gatterman N., Schneider W. Treatment of advanced myelodysplastic syndrome with recombinant interferon alpha-2b. Eur.J. Haematol. 1991; 46: 11–16
   PubMed Web of Science ®Google Scholar
• Avvisati G., Mandelli F. The role of interferon-alpha in the management of myelomatosis. Hematol. Oncol. Clin. North Am. 1992; 6: 395–405
   PubMed Web of Science ®Google Scholar
• Coutant G., Bletry O., Prin L., et al. Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases. Ann. Med. Interne. (Paris) 1993; 144: 243–250
   PubMedGoogle Scholar
• Peschel C., Aman M. J., Rudolf G., Aulitzky W. E., Huber C. Regulation of the cytokine network by interferon: a potential mechanism of interferon in chronic myelogenous leukemia. Seminars in Hematol. 1993; 30: 28–31
   PubMed Web of Science ®Google Scholar
• Petska S., Langer J. A., Zoon K. C., Samuel C. E. Inteferons and their actions. Ann. Rev. Biochem. 1987; 56: 727–777
   PubMed Web of Science ®Google Scholar
• Lengyel P. Tumor suppressor genes: news about the inteferon connection. PNAS 1993; 90: 5893–5895
   PubMed Web of Science ®Google Scholar
• Raefsky E. L., Platanias L. C., Zoumbos N. C., Young N. S. Studies of interferon as a regulator of hematopoietic cell proliferation. J. Immunol. 1985; 135: 2507–2512
   PubMed Web of Science ®Google Scholar
• Fisher P. B., Grand S. Effects of interferon on differentiation of normal and tumor cells. Pharmacol. Ther. 1985; 27: 143–166
   PubMed Web of Science ®Google Scholar
• Judware R., Petryshyn R. Partial characterization of a cellular factor that regulates the double-stranded RNA-dependent elF2a kinase in 3T3-F442A fibroblasts. Mol. Cell Biol. 1991; 11: 3259–3267
   PubMed Web of Science ®Google Scholar
• Zhang K., Kumar R. Interferon-alpha inhibits cyclin E- and cyclin D1 -dependent CDK-2 kinase activity associated with RB protein and E2Fin Daudi cells. Biochem. Biophys. Res. Commun. 1994; 200: 522–528
   PubMed Web of Science ®Google Scholar
• Sissolak G., Hoffbrand A. V., Mehta A. B., Ganeshaguru K. Interferon-alpha inducible 2'-5' oligoadenylate synthetase transcripts in lymphoid and myeloid leukemias. Leukemia 1993; 7: 712–716
   PubMed Web of Science ®Google Scholar
• Williams B. R. Signal transduction and transcriptional regulation of interferon-alpha stimulated genes. J. Interferon Res. 1991; 11: 207–213
   PubMedGoogle Scholar
• Vilcek J. Recent progress in the elucidation of interferon alpha/beta and interferon gamma actions. Seminars in Hematol. 1993; 30: 9–10
   PubMed Web of Science ®Google Scholar
• Pfeffer L. M., Colamonici O. R. Transmembrane signalling by inteferon-alpha. Pharmacol. Ther. 1991; 52: 149–157
   PubMed Web of Science ®Google Scholar
• Wood J. N., Hovanessian A. G. Interferon enhances 2'-5' A synthetase in embryonal carcinoma cells. Nature 1979; 282: 74–76
   PubMed Web of Science ®Google Scholar
• Clauss I. M., Vandenplas B., Walthelet M. G., et al. Analysis of interferon-inducible genes in cells of chronic myeloid leukemia. Patients responsive or resistant to an interferon-alpha treatment. Blood 1990; 76: 2337–2342
   PubMed Web of Science ®Google Scholar
• James R. I., Menaya J., Hudson K., et al. Role of protein kinase C in induction of gene expression and inhibition of cell proliferation by interferon alpha. Eur. J. Biochem. 1992; 209: 813–822
   PubMedGoogle Scholar
• Pulik M., Lionnet F., Petit A., Genet P., Gaulier A. Longterm response to Interferon-α in a patient with systemic mastocytosis and chronic myelomonocytic leukemia. J. Am. Hematol. 1994; 47: 66
   PubMed Web of Science ®Google Scholar